SCHEMBL5578003

SCHEMBL5578003

CC(C)(C)OC(=O)Nc1ccc(-c2cncn2-c2n[nH]c3nc(NC(=O)C4CC4)sc23)c(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.37
BRAF P15056 1/20 0.37
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CDK3 Q00526 1/20 0.36
LCK P06239 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MALT1 Q9UDY8 2/20 0.35
DGAT1 O75907 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577992 0.92 SUV39H2 (0.38) IDO1BRAFMEN1KMT2ACCNE1
SCHEMBL14454913 0.90 ABL1 (0.42) MEN1KMT2AMALT1LMNAHPGD
SCHEMBL14454968 0.89 MEN1 (0.40) MEN1KMT2ACCNE1CDK2CDK3
SCHEMBL14454914 0.87 MEN1 (0.39) MEN1KMT2ACCNE1CDK2CDK3
SCHEMBL14454967 0.86 MEN1 (0.38) MEN1KMT2ACCNE1CDK2CDK3
SCHEMBL14531234 0.85 MEN1 (0.35) BRAFMEN1KMT2ACCNE1CDK2
SCHEMBL5578089 0.85 CLK1 (0.36) BRAFMEN1KMT2AL3MBTL1HPGD
SCHEMBL14454919 0.85 PDK2 (0.36) BRAFMEN1KMT2AHPGDALDH1A1
SCHEMBL14454935 0.85 CASP3 (0.45) MEN1KMT2ALMNAHPGD
SCHEMBL14454899 0.85 ABL1 (0.43) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 IDO1 3254/4885BRAF 50/4885MEN1 3359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.